Categories: Budget

Budget reaction from Mr. Pavan Choudary, Chairman and Director General Medical Technology Association of India (MTaI)

New Delhi, July 09, 2019: “Reduction in Customs duty of Medical Devices in the Union budget would have furthered the government’s objective of increasing Healthcare affordability and accessibility, which, through Ayushman Bharat it is already trying to achieve. The increase in the turnover limit to INR 400 Crores under the 25% tax slab is in line with the government’s commitment in the Union budget 2015 to make Indian companies more competitive on the global business platform. This will also lead to increase in compliance and also attract more investment to India.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

17 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

3 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago

SpOvum® Launches ARTGPT Redefining Patient Support in Assisted Reproductive Technology (ART)

Launched for 1st time in India, ARTGPT is designed to address queries regarding A.R.T treatments Product created…

1 week ago